MEDPLUS HEALTH SERVICES has announced its results for the year ended March 2024. Let us have a look at the detailed performance review of the company during FY23-24.
No. of Mths Year Ending | 12 Mar-23* | 12 Mar-24* | % Change | |
---|---|---|---|---|
Net Sales | Rs m | 45,576 | 56,249 | 23.4% |
Other income | Rs m | 461 | 400 | -13.2% |
Total Revenues | Rs m | 46,037 | 56,649 | 23.1% |
Gross profit | Rs m | 2,814 | 3,713 | 32.0% |
Depreciation | Rs m | 1,816 | 2,242 | 23.5% |
Interest | Rs m | 987 | 1,136 | 15.1% |
Profit before tax | Rs m | 472 | 734 | 55.7% |
Tax | Rs m | -29 | 79 | NA |
Profit after tax | Rs m | 501 | 656 | 30.9% |
Gross profit margin | % | 6.2 | 6.6 | |
Effective tax rate | % | -6.2 | 10.7 | |
Net profit margin | % | 1.1 | 1.2 |
Don't Miss: Key Information for Long-term Investors
No. of Mths Year Ending | 12 Mar-23* | 12 Mar-24* | % Change | |
---|---|---|---|---|
Networth | Rs m | 14,607 | 15,476 | 5.9 |
Current Liabilities | Rs m | 4,766 | 5,259 | 10.4 |
Long-term Debt | Rs m | 0 | 0 | 0.0 |
Total Liabilities | Rs m | 27,645 | 29,430 | 6.5 |
Current assets | Rs m | 14,807 | 15,676 | 5.9 |
Fixed Assets | Rs m | 12,838 | 13,755 | 7.1 |
Total Assets | Rs m | 27,645 | 29,430 | 6.5 |
Particulars | No. of months | 12 | 12 | % Change |
---|---|---|---|---|
Year Ending | Mar-23 | Mar-24 | ||
Cash Flow from Operating Activities | Rs m | 904 | 1,437 | 59.0% |
Cash Flow from Investing Activities | Rs m | 4,294 | -828 | - |
Cash Flow from Financing Activities | Rs m | -1,702 | -1,981 | - |
Net Cash Flow | Rs m | 3,496 | -1,372 | - |
No. of Mths Year Ending | 12 Mar-23* | 12 Mar-24* | |
---|---|---|---|
Sales per share (Unadj.) | Rs | 382.0 | 470.5 |
TTM Earnings per share | Rs | 4.2 | 5.5 |
Diluted earnings per share | Rs | 4.2 | 5.5 |
Price to Cash Flow | x | 33.6 | 32.5 |
TTM P/E ratio | x | 155.4 | 115.1 |
Price / Book Value ratio | x | 6.6 | 6.1 |
Market Cap | Rs m | 96,459 | 94,159 |
Dividends per share (Unadj.) | Rs | 0.0 | 0.0 |
Current Ratio: The company's current ratio deteriorated and stood at 3.0x during FY24, from 3.1x during FY23. The current ratio measures the company's ability to pay short-term and long-term obligations.
Interest Coverage Ratio: The company's interest coverage ratio improved and stood at 1.6x during FY24, from 1.5x during FY23. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.
Return on Equity (ROE): The ROE for the company improved and stood at 4.2% during FY24, from 3.4% during FY24. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.
Return on Capital Employed (ROCE): The ROCE for the company improved and stood at 12.1% during FY24, from 10.0% during FY23. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.
Return on Assets (ROA): The ROA of the company improved and stood at 6.1% during FY24, from 5.4% during FY23. The ROA measures how efficiently the company uses its assets to generate earnings.
No. of Mths Year Ending | 12 Mar-23* | 12 Mar-24* | |
---|---|---|---|
Current ratio | x | 3.1 | 3.0 |
Debtors’ Days | Days | 1 | 1 |
Interest coverage | x | 1.5 | 1.6 |
Debt to equity ratio | x | 0.0 | 0.0 |
Return on assets | % | 5.4 | 6.1 |
Return on equity | % | 3.4 | 4.2 |
Return on capital employed | % | 10.0 | 12.1 |
To see how MEDPLUS HEALTH SERVICES has performed over the last 5 years, please visit here.
Over the last one year, MEDPLUS HEALTH SERVICES share price has moved down from Rs 808.0 to Rs 733.0, registering a loss of Rs 75.0 or around 9.3%.
Overall, the S&P BSE SENSEX is up 23.3% over the year.
(To know more, check out historical annual results for MEDPLUS HEALTH SERVICES and quarterly results for MEDPLUS HEALTH SERVICES)
MEDPLUS HEALTH SERVICES currently trades at Rs 734.8 per share. You can check out the latest share price performance of MEDPLUS HEALTH SERVICES here...
The revenues of MEDPLUS HEALTH SERVICES stood at Rs 56,649 m in FY24, which was up 23.1% compared to Rs 46,037 m reported in FY23.
MEDPLUS HEALTH SERVICES' revenue has grown from Rs 28,879 m in FY20 to Rs 56,649 m in FY24.
Over the past 5 years, the revenue of MEDPLUS HEALTH SERVICES has grown at a CAGR of 18.3%.
The net profit of MEDPLUS HEALTH SERVICES stood at Rs 656 m in FY24, which was up 30.9% compared to Rs 501 m reported in FY23.
This compares to a net profit of Rs 947 m in FY22 and a net profit of Rs 631 m in FY21.
Over the past 5 years, MEDPLUS HEALTH SERVICES net profit has grown at a CAGR of 145.9%.
The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.
This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.
The cash flow statement of MEDPLUS HEALTH SERVICES reveals:
Here's the cash flow statement of MEDPLUS HEALTH SERVICES for the past 5 years.
(Rs m) | FY20 | FY21 | FY22 | FY23 | FY24 |
---|---|---|---|---|---|
From Operations | -66 | 29 | 1,699 | 904 | 1,437 |
From Investments | -276 | -345 | -7,031 | 4,294 | -828 |
From Financial Activity | 898 | -56 | 4,404 | -1,702 | -1,981 |
Net Cashflow | 557 | -373 | -928 | 3,496 | -1,372 |
Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.
The ratio/financial analysis of MEDPLUS HEALTH SERVICES reveals:
Here's the ratio/financial analysis of MEDPLUS HEALTH SERVICES for the past 5 years.
FY20 | FY21 | FY22 | FY23 | FY24 | |
---|---|---|---|---|---|
Operating Profit Margin (%) | 4.7 | 7.5 | 7.6 | 6.2 | 6.6 |
Net Profit Margin (%) | 0.1 | 2.1 | 2.5 | 1.1 | 1.2 |
Debt to Equity Ratio (x) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Equitymaster requests your view! Post a comment on "MEDPLUS HEALTH SERVICES 2023-24 Annual Report Analysis". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!